BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 16079188)

  • 1. A role for proteinase-activated receptor 2 and PKC-epsilon in thrombin-mediated induction of decay-accelerating factor on human endothelial cells.
    Lidington EA; Steinberg R; Kinderlerer AR; Landis RC; Ohba M; Samarel A; Haskard DO; Mason JC
    Am J Physiol Cell Physiol; 2005 Dec; 289(6):C1437-47. PubMed ID: 16079188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of decay-accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase C-dependent pathway protects vascular endothelial cells from complement-mediated injury.
    Lidington EA; Haskard DO; Mason JC
    Blood; 2000 Oct; 96(8):2784-92. PubMed ID: 11023512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decay-accelerating factor induction on vascular endothelium by vascular endothelial growth factor (VEGF) is mediated via a VEGF receptor-2 (VEGF-R2)- and protein kinase C-alpha/epsilon (PKCalpha/epsilon)-dependent cytoprotective signaling pathway and is inhibited by cyclosporin A.
    Mason JC; Steinberg R; Lidington EA; Kinderlerer AR; Ohba M; Haskard DO
    J Biol Chem; 2004 Oct; 279(40):41611-8. PubMed ID: 15284224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4.
    Ramachandran R; Sadofsky LR; Xiao Y; Botham A; Cowen M; Morice AH; Compton SJ
    Am J Physiol Lung Cell Mol Physiol; 2007 Mar; 292(3):L788-98. PubMed ID: 17142351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins prevent tissue factor induction by protease-activated receptors 1 and 2 in human umbilical vein endothelial cells in vitro.
    Banfi C; Brioschi M; Lento S; Pirillo A; Galli S; Cosentino S; Tremoli E; Mussoni L
    J Thromb Haemost; 2011 Aug; 9(8):1608-19. PubMed ID: 21605334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. bFGF and VEGF synergistically enhance endothelial cytoprotection via decay-accelerating factor induction.
    Mason JC; Lidington EA; Ahmad SR; Haskard DO
    Am J Physiol Cell Physiol; 2002 Mar; 282(3):C578-87. PubMed ID: 11832343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial reactive oxygen species: a common pathway for PAR1- and PAR2-mediated tissue factor induction in human endothelial cells.
    Banfi C; Brioschi M; Barbieri SS; Eligini S; Barcella S; Tremoli E; Colli S; Mussoni L
    J Thromb Haemost; 2009 Jan; 7(1):206-16. PubMed ID: 18983479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1.
    O'Brien PJ; Prevost N; Molino M; Hollinger MK; Woolkalis MJ; Woulfe DS; Brass LF
    J Biol Chem; 2000 May; 275(18):13502-9. PubMed ID: 10788464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of the specificity of protease-activated receptors 1 and 2 signaling by factor Xa and thrombin.
    Rana S; Yang L; Hassanian SM; Rezaie AR
    J Cell Biochem; 2012 Mar; 113(3):977-84. PubMed ID: 22034092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease-activated receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from thrombin signaling.
    Riewald M; Ruf W
    J Biol Chem; 2005 May; 280(20):19808-14. PubMed ID: 15769747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of Rho GTPase activity in endothelial cells by selective proteinase-activated receptor (PAR) agonists.
    Vouret-Craviari V; Grall D; Van Obberghen-Schilling E
    J Thromb Haemost; 2003 May; 1(5):1103-11. PubMed ID: 12871383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine upregulation of proteinase-activated-receptors 2 and 4 expression mediated by p38 MAP kinase and inhibitory kappa B kinase beta in human endothelial cells.
    Ritchie E; Saka M; Mackenzie C; Drummond R; Wheeler-Jones C; Kanke T; Plevin R
    Br J Pharmacol; 2007 Apr; 150(8):1044-54. PubMed ID: 17339845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease-activated receptor-2 (PAR2) mediates VEGF production through the ERK1/2 pathway in human glioblastoma cell lines.
    Dutra-Oliveira A; Monteiro RQ; Mariano-Oliveira A
    Biochem Biophys Res Commun; 2012 May; 421(2):221-7. PubMed ID: 22497886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct roles of protease-activated receptors in signal transduction regulation of endothelial nitric oxide synthase.
    Suzuki H; Motley ED; Eguchi K; Hinoki A; Shirai H; Watts V; Stemmle LN; Fields TA; Eguchi S
    Hypertension; 2009 Feb; 53(2):182-8. PubMed ID: 19064814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of endothelial cell decay-accelerating factor by vascular endothelial growth factor: a mechanism for cytoprotection against complement-mediated injury during inflammatory angiogenesis.
    Mason JC; Lidington EA; Yarwood H; Lublin DM; Haskard DO
    Arthritis Rheum; 2001 Jan; 44(1):138-50. PubMed ID: 11212152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transactivation of the PAR1-PAR2 heterodimer by thrombin elicits β-arrestin-mediated endosomal signaling.
    Lin H; Trejo J
    J Biol Chem; 2013 Apr; 288(16):11203-15. PubMed ID: 23476015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinase-activated receptor-1 (PAR1) and PAR2 mediate relaxation of guinea pig internal anal sphincter.
    Huang SC
    Regul Pept; 2014 Feb; 189():46-50. PubMed ID: 24631471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis.
    Shi X; Gangadharan B; Brass LF; Ruf W; Mueller BM
    Mol Cancer Res; 2004 Jul; 2(7):395-402. PubMed ID: 15280447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unproductive cleavage and the inactivation of protease-activated receptor-1 by trypsin in vascular endothelial cells.
    Nakayama T; Hirano K; Shintani Y; Nishimura J; Nakatsuka A; Kuga H; Takahashi S; Kanaide H
    Br J Pharmacol; 2003 Jan; 138(1):121-30. PubMed ID: 12522081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease activated receptors 1 and 4 sensitize TRPV1 in nociceptive neurones.
    Vellani V; Kinsey AM; Prandini M; Hechtfischer SC; Reeh P; Magherini PC; Giacomoni C; McNaughton PA
    Mol Pain; 2010 Sep; 6():61. PubMed ID: 20875131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.